VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRAI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRAICRA International, Inc.
$197.66$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRAIFinancials

CRA International, Inc. (CRAI) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has accelerated to 12.8% year-over-year in Q2 2026, but gross margins have compressed significantly to 26.2% in Q1 2026, suggesting a structural shift in business mix is eroding profitability despite top-line strength.

Income StatementBalance SheetCash FlowRatios

CRAI Income Statement

Annual statement

CRAI Income Statement

CRA International, Inc. (CRAI) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMOct'26Jan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Nov'10Nov'09Nov'08Nov'07Nov'06Nov'05Nov'04Nov'03Nov'02Nov'01Nov'00Nov'99Nov'98Nov'97
Sales/Revenue823.67M626.71M751.58M687.41M623.98M590.9M565.93M508.37M451.37M417.65M370.07M324.78M303.56M306.37M278.43M270.39M305.23M309.67M301.64M376.75M394.64M349.89M295.47M216.74M163.46M130.69M109.8M82.55M74M53M44.8M
Revenue Growth %12.67%-16.62%9.33%10.17%5.6%4.41%11.32%12.63%8.07%12.86%13.95%6.99%-0.92%10.03%2.97%-11.41%-1.44%2.66%-19.94%-4.53%12.79%18.42%36.33%32.59%25.07%19.02%33.02%11.55%39.62%18.3%-
Cost of Goods Sold599.11M0533.43M479.94M452.25M410.08M400.05M370.71M317.76M289.19M258.83M227.38M207.65M206.81M189.26M182.38M199.38M213.54M199.86M250.11M246.01M221.34M174.72M127.72M100.17M80.66M65.59M44.3M40.2M30.7M27.7M
COGS % of Revenue--70.97%69.82%72.48%69.4%70.69%72.92%70.4%69.24%69.94%70.01%68.41%67.5%67.97%67.45%65.32%68.96%66.26%66.39%62.34%63.26%59.13%58.93%61.28%61.72%59.73%53.66%54.32%57.92%61.83%
Gross Profit224.56M0218.16M207.48M171.73M180.82M165.88M137.66M133.61M128.46M111.25M97.4M95.91M99.56M89.17M88.01M105.84M96.13M101.78M126.64M148.63M128.55M120.75M89.02M63.29M50.03M44.21M38.25M33.8M22.3M17.1M
Gross Margin %27.26%-29.03%30.18%27.52%30.6%29.31%27.08%29.6%30.76%30.06%29.99%31.59%32.5%32.03%32.55%34.68%31.04%33.74%33.61%37.66%36.74%40.87%41.07%38.72%38.28%40.27%46.34%45.68%42.08%38.17%
Gross Profit Growth %--100%5.15%20.82%-5.03%9.01%20.5%3.03%4.01%15.48%14.22%1.55%-3.67%11.65%1.32%-16.85%10.1%-5.55%-19.63%-14.79%15.62%6.46%35.65%40.65%26.5%13.16%15.59%13.17%51.57%30.41%-
Operating Expenses138.46M105.19M135.03M136.73M115.12M122.08M110.14M102.87M104.26M99.53M95.48M78.48M78.99M75.52M70.65M74.42M76.78M86.53M84.64M105.5M99.86M80.6M76.56M57.29M43.05M36.6M31.56M23.98M19.5M12.8M12.4M
OpEx % of Revenue-16.78%17.97%19.89%18.45%20.66%19.46%20.23%23.1%23.83%25.8%24.16%26.02%24.65%25.38%27.53%25.16%27.94%28.06%28%25.3%23.04%25.91%26.43%26.34%28.01%28.74%29.05%26.35%24.15%27.68%
Selling, General & Admin138.88M105.19M135.03M125.05M115.12M110.09M97.37M90.03M93.61M89.53M86.54M70.58M72.44M69.07M64.24M67.23M71.75M80.04M76.12M105.5M99.86M80.6M76.56M57.29M43.05M36.6M31.56M21.84M17.4M11.9M11.7M
SG&A % of Revenue-16.78%17.97%18.19%18.45%18.63%17.21%17.71%20.74%21.44%23.38%21.73%23.86%22.55%23.07%24.87%23.51%25.85%25.24%28%25.3%23.04%25.91%26.43%26.34%28.01%28.74%26.45%23.51%22.45%26.12%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses1000K0011.68M012M12.77M12.84M10.65M387K-366K-397K-647K-295K-180K-177K5.03M6.49M8.52M000000002.14M2.1M900K700K
Operating Income86.1M65.47M83.12M70.75M56.61M58.74M55.74M34.8M29.35M28.93M15.76M18.92M12.39M24.04M18.52M-57.81M29.06M9.6M17.13M21.15M48.77M47.95M44.19M31.73M20.23M13.43M12.66M14.27M14.3M9.5M4.7M
Operating Margin %10.45%10.45%11.06%10.29%9.07%9.94%9.85%6.84%6.5%6.93%4.26%5.83%4.08%7.85%6.65%-21.38%9.52%3.1%5.68%5.61%12.36%13.7%14.95%14.64%12.38%10.28%11.53%17.29%19.32%17.92%10.49%
Operating Income Growth %--21.24%17.49%24.98%-3.62%5.38%60.19%18.56%1.43%83.55%-16.68%52.65%-48.45%29.83%132.03%-298.91%202.72%-43.96%-18.98%-56.64%1.71%8.52%39.25%56.82%50.66%6.11%-11.3%-0.2%50.53%102.13%-
EBITDA110.86M75.38M112.63M97.58M82.45M84.49M81.52M59.67M50.66M38.93M24.71M26.82M18.95M30.48M24.93M-50.62M34.09M15.96M25.65M30.54M58.93M58.23M52.31M36.86M24M16.4M16.03M16.41M16.4M10.4M5.4M
EBITDA Margin %13.46%12.03%14.99%14.19%13.21%14.3%14.4%11.74%11.22%9.32%6.68%8.26%6.24%9.95%8.95%-18.72%11.17%5.15%8.5%8.11%14.93%16.64%17.7%17.01%14.68%12.55%14.6%19.88%22.16%19.62%12.05%
EBITDA Growth %-1.91%-33.08%15.43%18.35%-2.41%3.64%36.61%17.8%30.13%57.55%-7.85%41.53%-37.85%22.29%149.25%-248.48%113.58%-37.78%-16%-48.18%1.21%11.31%41.92%53.6%46.33%2.31%-2.34%0.08%57.69%92.59%-
D&A (Non-Cash Add-back)24.76M9.91M29.51M26.82M25.84M25.75M25.78M24.88M21.31M9.99M8.95M7.9M6.55M6.44M6.41M7.19M5.03M6.36M8.52M9.39M10.16M10.28M8.12M5.13M3.76M2.97M3.37M2.14M2.1M900K700K
EBIT83.39M081.93M70.66M56.1M60.63M55.24M34.84M28.05M29.58M15.65M22.36M12.35M23.75M18.49M-57.72M28.99M8.79M17.49M25.59M48.77M47.95M44.19M31.73M20.23M13.43M12.66M14.27M14.3M9.5M4.7M
Net Interest Income-5.93M0-5.36M-4.42M-3.81M-1.83M-970K-1.22M-1.25M-647K-484K-469K-538K-431K-419K-36K-576K-3.11M-3.93M-346K2.18M1.67M-1.22M-847K85K337K1.04M1.54M000
Interest Income00000000000045K163K155K264K332K390K451K3.13M5.51M5.09M2.15M904K85K337K1.04M1.54M000
Interest Expense5.93M-6.57M5.36M4.42M3.81M1.83M970K1.22M1.25M647K484K469K583K594K574K300K911K3.5M2.92M3.48M3.34M3.42M3.37M1.75M0000000
Other Income/Expense-8.65M-6.6M-6.55M-4.51M-4.32M63K-1.46M-1.17M-2.55M-2K-600K2.97M-579K-726K-599K-78.31M-981K-4.31M-1.84M2.12M1.74M1.46M-999K-1.11M-69K884K1.04M734K900K1.2M600K
Pretax Income77.45M58.86M76.57M66.24M52.29M58.8M54.27M33.62M26.8M28.93M15.16M21.89M11.81M23.32M17.92M-58.02M28.08M5.29M15.29M23.27M50.51M49.41M43.19M30.63M20.17M14.31M13.7M15.01M15.2M10.7M5.3M
Pretax Margin %9.4%9.39%10.19%9.64%8.38%9.95%9.59%6.61%5.94%6.93%4.1%6.74%3.89%7.61%6.44%-21.46%9.2%1.71%5.07%6.18%12.8%14.12%14.62%14.13%12.34%10.95%12.48%18.18%20.54%20.19%11.83%
Income Tax25.72M20.32M21.79M19.59M13.81M15.18M12.6M9.12M6.05M6.46M7.46M7.66M5.49M9.91M6.68M-5.18M11.14M3.98M8.09M14.24M19.7M21.18M18.53M13.95M8.74M5.88M5.85M6.17M6.2M4.3M300K
Effective Tax Rate %33.21%34.51%28.46%29.57%26.41%25.82%23.21%27.11%22.58%22.33%49.22%34.98%46.47%42.5%37.3%8.93%39.66%75.37%52.91%61.19%39%42.87%42.9%45.54%43.33%41.07%42.68%41.09%40.79%40.19%5.66%
Net Income51.73M38.55M54.78M46.65M38.48M43.62M41.68M24.51M20.75M22.49M7.62M12.89M7.66M13.64M11.37M-52.99M16.85M1.96M7.82M8.7M32.6M27.45M24.6M16.34M11.43M8.44M7.44M8.84M9M6.4M5M
Net Margin %6.28%6.15%7.29%6.79%6.17%7.38%7.36%4.82%4.6%5.39%2.06%3.97%2.52%4.45%4.08%-19.6%5.52%0.63%2.59%2.31%8.26%7.84%8.33%7.54%6.99%6.46%6.77%10.71%12.16%12.08%11.16%
Net Income Growth %-8.58%-29.64%17.42%21.24%-11.78%4.65%70.07%18.12%-7.76%195.02%-40.84%68.32%-43.86%19.95%121.46%-414.46%759.74%-74.93%-10.19%-73.3%18.79%11.56%50.51%43%35.48%13.4%-15.84%-1.79%40.63%28%-
Net Income (Continuing)51.73M38.55M54.78M46.65M38.48M43.62M41.68M24.51M20.75M22.47M7.7M14.23M6.33M13.41M11.23M-52.84M16.95M1.3M7.2M9.03M32.6M28.23M24.6M16.34M11.43M8.44M7.44M8.84M9M6.4M5M
Discontinued Operations0000000000000000000-679K0-786K000000000
Minority Interest0-00000000321K663K-688K619K839K958K803K670K1.6M2.09M002.24M2.19M1.85M1.7M2.24M1.83M00300K
EPS (Diluted)8.185.988.146.745.395.915.453.072.532.620.891.490.831.381.12-5.211.570.180.730.742.682.242.131.551.160.910.811.011.050.840.78
EPS Growth %-4.09%-26.54%20.77%25.05%-8.8%8.44%77.52%21.34%-3.44%194.38%-40.27%79.52%-39.86%23.21%121.5%-431.85%772.22%-75.34%-1.35%-72.39%19.64%5.16%37.42%33.62%27.47%12.35%-19.8%-3.81%25%7.69%-
EPS (Basic)-6.048.236.825.476.025.593.142.632.620.911.500.841.401.13-5.211.600.180.740.762.912.402.341.631.210.930.821.011.070.840.78
Diluted Shares Outstanding6.33M6.44M6.71M6.91M7.12M7.36M7.62M7.95M8.17M8.57M8.5M8.6M9.2M9.9M10.17M10.17M10.74M10.75M10.72M10.9M12.15M12.27M11.56M10.52M9.84M9.28M9.22M8.77M8.57M7.62M6.41M
Basic Shares Outstanding6.26M6.37M6.64M6.82M7.01M7.22M7.42M7.77M7.87M8.57M8.29M8.5M9.01M9.75M10.08M10.17M10.55M10.64M10.61M10.61M11.22M11.42M10.53M10.02M9.44M9.05M9.11M8.73M8.48M7.57M6.41M
Dividend Payout Ratio--25.25%26.36%28.08%21.96%19.89%30.62%32.7%26.85%64.81%9.05%-----------------182.81%32%

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

High dependency on specialized talent

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Accelerating Demand for Expert Testimony

CRAI's revenue growth accelerated to 12.8% year-over-year in Q2 2026, a notable uptick from the trailing twelve-month rate of 9.3%, suggesting strengthening demand for its specialized litigation support.

This acceleration appears to validate the firm's strategy of leveraging its academic network in a favorable regulatory environment, as cited in recent context flags. The durable, multi-year nature of major antitrust cases provides a structural tailwind, but the growth's sustainability will depend on the firm's ability to continue converting legal mandates into consistent billings.

Structural Margin Compression from Mix Shift

Gross margins have compressed from over 30% in mid-2025 to 26.2% in Q1 2026, a trend that suggests the Management Consulting segment may be diluting the profitability profile of the higher-margin litigation work.

The reported 29.03% gross margin reflects the high cost of recruiting and retaining PhD-level talent, which acts as a permanent drag on the margin structure compared to peers like Exponent. Based on the data, the firm's operating margin now trails both Huron (11.7%) and FTI (9.6% in certain segments), indicating that pricing power may be insufficient to fully offset rising labor costs and potential mix shifts.

Inconsistent Operating Leverage Execution

Despite consistent revenue growth, operating margin has been volatile, ranging from 6.6% to 14.0% over the past ten quarters, indicating that cost growth has at times outpaced revenue gains.

This volatility suggests that the firm's cost structure is not fully fixed, and its ability to generate leverage from incremental revenue is inconsistent. While SG&A as a percentage of revenue has shown modest improvement, the primary challenge lies in managing the variable compensation and expert fees that form the core of COGS, making margin expansion highly sensitive to utilization rates and billing mix.

EPS Volatility from Non-Operating Factors

Diluted EPS has swung wildly, including a -35.5% decline in Q1 2026 despite a 10.5% revenue increase, pointing to significant non-operational items impacting the bottom line.

The disconnect between revenue growth and EPS growth indicates the influence of factors like variable compensation, tax rates, or other non-operating items, which complicates trend analysis. Investors should focus on operating income trends as a cleaner proxy for the core business performance, as net income appears subject to considerable quarter-to-quarter noise.

Labor-Centric Cost Structure Limits Flexibility

With zero reported R&D and minimal capital expenditure, consultant compensation represents the dominant and almost singular cost driver, making the firm highly sensitive to wage inflation in the competitive PhD talent market.

The cost structure is fundamentally tied to human capital, with SG&A also likely driven by support staff and recruiting. This leaves very little room for cost reduction without impacting service quality or capacity. The firm's low debt-to-equity ratio of 0.60% provides financial flexibility, but does not mitigate the operational pressure of maintaining a bench of world-class experts.

Margin Compression Threatens Growth Narrative

The strongest counter-argument is that accelerating top-line growth is masking a structural decline in profitability, as evidenced by a 500 basis point drop in gross margin since Q2 2025.

Short-sellers would focus on whether the mix is permanently shifting toward lower-margin work or if labor costs are becoming unsustainable without corresponding pricing power. The firm's unique niche may protect it from pure-play competition, but it does not insulate it from the economic reality that its core 'asset'—expert talent—is becoming more expensive to acquire and retain, a risk that current guidance may underappreciate.

CRAI — Frequently Asked Questions

Quick answers to the most common questions about buying CRAI stock.

What was CRA International, Inc.'s (CRAI) revenue in 2026?

For fiscal year 2026, CRA International, Inc. (CRAI) reported total revenue of $626.7M. This represents a 1298.9% increase compared to $44.8M in 1997.

Is CRA International, Inc. (CRAI) profitable?

CRA International, Inc. (CRAI) is profitable, generating $38.5M in net income for the fiscal year ending 2026 with a net profit margin of 6.2%.

What is CRA International, Inc.'s operating profit margin?

CRA International, Inc. (CRAI) reported an operating income of $65.5M, resulting in an operating profit margin of 10.4%. This margin reflects the operational efficiency of the business before interest and taxes.